HEXO HEXO Corp.

The Hydropothecary Corp is in the business of producing, marketing and selling of medical marijuana through its indirect wholly-owned subsidiary. The product lines include H2, Decarb, and Elixir No. 1.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:HEXO.

$6.19  +0.11 (1.81%)
As of 05/13/2021 10:16:30 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Canada
Country of incorporation:  
IPO date:  01/08/2013
Outstanding shares:  122,484,968
Average volume:  3,618,435
Market cap:   $884,341,469
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      40-F
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -3.79
PB ratio:   1.49
PS ratio:   7.92
Return on equity:   -39.42%
Net income %:   -190.94%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy